We identified methylation in YOD1, UGT8, FNDC3B, and SLIT2 as new epigenetic factors associated with late-life MDD, which are not confounded by cognitive status or a genetic risk for MDD and stronger associated with MDD in male than in female. Here, YOD1 is linked to major depressive disorder.